AbCellera Biologics Inc. (ABCL) Social Stream
ABCELLERA BIOLOGICS INC (ABCL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ABCL.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 4 | $55 | $25 | $45.25 | $10.46 | 332.6% |
| 2021-12-05 | 5 | $53 | $25 | $40.8 | $10.46 | 290.06% |
| 2021-12-19 | 7 | $53 | $25 | $39.833 | $10.46 | 280.81% |
| 2021-12-21 | 7 | $53 | $25 | $38 | $10.46 | 263.29% |
| 2022-02-11 | 5 | $45 | $25 | $33 | $10.46 | 215.49% |
| 2022-02-25 | 5 | $40 | $20 | $30 | $10.46 | 186.81% |
| 2022-05-09 | 5 | $40 | $20 | $29.6 | $10.46 | 182.98% |
| 2022-05-11 | 5 | $32 | $14 | $24.8 | $10.46 | 137.09% |
| 2022-08-09 | 5 | $32 | $14 | $23.6 | $10.46 | 125.62% |
| 2022-08-11 | 5 | $34 | $14 | $24 | $10.46 | 129.45% |
The Trend in the Analyst Price Target
Over the past 49 weeks, ABCL's average price target has gone down $21.4.
Over the past 48 weeks, ABCL's average upside potential has been 193.89%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-19 | 2 | 55 | 25 | 45.40 | 20.36 | 122.99% |
| 2021-11-09 | 5 | 55 | 25 | 45.25 | 14.71 | 207.61% |
| 2021-12-05 | 5 | 53 | 25 | 40.80 | 14.02 | 191.01% |
| 2022-01-07 | 5 | 45 | 25 | 33.00 | 11.82 | 179.19% |
| 2022-07-26 | 5 | 32 | 14 | 23.60 | 10.19 | 131.6% |
ABCL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 26 weeks, ABCL's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ABCL as an investment opportunity.
- In the context of all US stocks, ABCELLERA BIOLOGICS INC's upside potential (average analyst target price relative to current price) is higher than 1247.74% of them.
- In terms of how ABCELLERA BIOLOGICS INC fares relative to stocks in the large market cap category, note that its number of analysts covering the stock is higher than 120.81% of that group.
- In terms of how ABCELLERA BIOLOGICS INC fares relative to stocks in the large market cap category, note that its average analyst price target is higher than 261.43% of that group.
- In terms of how ABCELLERA BIOLOGICS INC fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than -1071.26% of that group.
In the Pharmaceutical Products industry, VIR, VCEL, and TIL are the three stocks most similar to ABCELLERA BIOLOGICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding ABCL using the data that counts. Try POWR Ratings for free.